Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 1
2004 2
2005 5
2006 5
2007 2
2008 6
2009 5
2010 2
2011 8
2012 7
2013 7
2014 13
2015 11
2016 7
2017 10
2018 7
2019 4
2020 10
2021 15
2022 13
2023 9
2024 7
2025 16
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High Advanced Gastric or Esophagogastric Junction Cancer.
Kawakami H, Kadowaki S, Makiyama A, Tsuda M, Hirata K, Sugimoto N, Machida N, Hara H, Hirano H, Esaki T, Komatsu Y, Hironaka S, Kobayashi Y, Kakimi K, Chiba Y, Boku N, Hyodo I, Muro K. Kawakami H, et al. Among authors: kakimi k. J Clin Oncol. 2025 Jul;43(19):2184-2195. doi: 10.1200/JCO-24-02463. Epub 2025 May 16. J Clin Oncol. 2025. PMID: 40378356 Clinical Trial.
Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape.
Takeuchi Y, Tanegashima T, Sato E, Irie T, Sai A, Itahashi K, Kumagai S, Tada Y, Togashi Y, Koyama S, Akbay EA, Karasaki T, Kataoka K, Funaki S, Shintani Y, Nagatomo I, Kida H, Ishii G, Miyoshi T, Aokage K, Kakimi K, Ogawa S, Okumura M, Eto M, Kumanogoh A, Tsuboi M, Nishikawa H. Takeuchi Y, et al. Among authors: kakimi k. Sci Immunol. 2021 Nov 12;6(65):eabc6424. doi: 10.1126/sciimmunol.abc6424. Epub 2021 Nov 12. Sci Immunol. 2021. PMID: 34767457
Advances in personalized cancer immunotherapy.
Kakimi K, Karasaki T, Matsushita H, Sugie T. Kakimi K, et al. Breast Cancer. 2017 Jan;24(1):16-24. doi: 10.1007/s12282-016-0688-1. Epub 2016 Mar 21. Breast Cancer. 2017. PMID: 27000871 Review.
[Neoantigens and Whole-Exome Sequencing].
Karasaki T, Nakajima J, Kakimi K. Karasaki T, et al. Among authors: kakimi k. Gan To Kagaku Ryoho. 2016 Jul;43(7):791-7. Gan To Kagaku Ryoho. 2016. PMID: 27431622 Review. Japanese.
Chromosomal Instability Is Associated with cGAS-STING Activation in EGFR-TKI Refractory Non-Small-Cell Lung Cancer.
Yonesaka K, Kurosaki T, Tanizaki J, Kawakami H, Tanaka K, Maenishi O, Takamura S, Sakai K, Chiba Y, Teramura T, Goto H, Otsuka E, Okida H, Funabashi M, Hashimoto Y, Hirotani K, Kamai Y, Kagari T, Nishio K, Kakimi K, Hayashi H. Yonesaka K, et al. Among authors: kakimi k. Cells. 2025 Mar 17;14(6):447. doi: 10.3390/cells14060447. Cells. 2025. PMID: 40136696 Free PMC article.
Combination of ionizable lipids with oleic acid and vitamin E scaffolds for RNA cancer vaccine delivery.
Anindita J, Tanaka H, Oyama R, Matsumaru A, Nakai Y, Tange K, Nagaoka K, Nakanishi H, Kawamura T, Tanaka T, Yamashita T, Kuroda A, Nomura S, Hatakeyama H, Itaka K, Kodama T, Kakimi K, Akita H. Anindita J, et al. Among authors: kakimi k. J Control Release. 2026 Jan 10;389:114414. doi: 10.1016/j.jconrel.2025.114414. Epub 2025 Nov 17. J Control Release. 2026. PMID: 41260268 Free article.
157 results